10x Genomics Inc - Class A

NASDAQ: TXG
$15.00
-$0.08 (-0.5%)
Closing Price on January 31, 2025

TXG Stock Chart and Intraday Price

TXG Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 5,429.25M USD
Shares Outstanding 105,110,000
10x Genomics Inc is a pioneering life science technology firm based in Pleasanton, California, specializing in developing instruments, consumables, and software for analyzing biological systems. Its innovative product lineup includes the Chromium and Visium platforms, offering solutions for single cell gene expression, immune profiling, and spatial analysis of biological samples. These tools are crucial for researchers in academia, government, and the biopharmaceutical industry, aiming to unlock complex biological insights at the cellular and molecular levels.

TXG Articles

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns. Notably,...
Thursday's additional top analyst upgrades and downgrades were on Analog Devices, Bed Bath & Beyond, Hasbro, Krispy Kreme, 10X Genomics, Verizon Communications and more.
Friday's additional top analyst upgrades and downgrades included Allogene Therapeutics, CSX, Norfolk Southern, Qualcomm, Toyota and Yelp.
Stocks were trading lower in Thursday's premarket. Here is a look at the leaders and the laggards.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.